Polymyositis-dermatomyositis-associated interstitial lung disease.

Area of Science:

• Rheumatology
• Pulmonology
• Immunology

Background:

• Polymyositis (PM) and dermatomyositis (DM) are inflammatory myopathies.
• Interstitial lung disease (ILD) is a significant complication of PM/DM.
• Understanding the presentation and outcomes of PM/DM-ILD is crucial for patient management.

Purpose of the Study:

• To characterize the clinical presentation, diagnostic findings, treatment, and outcomes of patients with PM/DM-associated ILD.
• To compare survival in this cohort with historical controls.

Main Methods:

• Retrospective analysis of 70 patients with PM/DM and ILD.
• Review of clinical symptoms, imaging (chest X-ray, CT), serological markers (Jo-1 antibody), and surgical lung biopsies.
• Assessment of treatment regimens and survival data.

Main Results:

• Musculoskeletal or pulmonary symptoms were common initial presentations.
• Antibiotic-resistant pneumonia and bilateral lung opacities were frequent findings.
• Nonspecific interstitial pneumonia (NSIP) was the predominant biopsy finding (81.8%).
• Survival was better than idiopathic usual interstitial pneumonia (UIP) and similar to idiopathic NSIP.

Conclusions:

• PM/DM-ILD often presents with distinct pulmonary findings and NSIP histology.
• Treatment with corticosteroids and immunosuppressants improves outcomes.
• PM/DM-ILD prognosis is more favorable than previously thought for ILD.